Evidence map›Paper›PMID 42818581›Full record

ArticleFrontiers in oncology2026

Comparative analysis of two-dimensional and three-dimensional machine learning models for predicting the degree of invasion in lung non-mucinous adenocarcinomas presenting as subsolid nodules.

Yi-Ming Hui, Ming-Zhi Lin, Bin Li, Yu-Qi Meng, Hai-Ming Feng, Yu-Zhen Chen, Zhi-Peng Su

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yi-Ming HuiDepartment of Thoracic Surgery, The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, Gansu, China.
Ming-Zhi LinDepartment of Thoracic Surgery, The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, Gansu, China.
Bin LiDepartment of Thoracic Surgery, The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, Gansu, China.
Yu-Qi MengDepartment of Thoracic Surgery, The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, Gansu, China.
Hai-Ming FengDepartment of Thoracic Surgery, The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, Gansu, China.
Yu-Zhen ChenDepartment of Thoracic Surgery, The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, Gansu, China.
Zhi-Peng SuDepartment of Thoracic Surgery, The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, Gansu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Most malignant subsolid nodules (SSNs) are non-mucinous adenocarcinomas, and prognosis varies substantially with the degree of invasion. Previous studies have shown that the solid component of SSNs is closely associated with invasiveness. With advances in image analysis, three-dimensional (3D) computed tomography (CT) features may provide more comprehensive information than conventional two-dimensional (2D) measurements. This study aimed to investigate the value of 2D and 3D CT features for predicting the extent of invasion in SSNs and to compare the diagnostic performance and potential clinical utility of 2D- and 3D-based predictive models. Materials and methods: This single-center retrospective model-development study included 234 SSNs from 223 patients with pathologically confirmed lung non-mucinous adenocarcinoma. Minimally invasive adenocarcinoma and Grade 1 tumors were classified as the low-risk group, whereas Grades 2 and 3 tumors were classified as the high-risk group. Patients were randomly assigned at the patient level to a training set comprising 171 SSNs from 164 patients and a held-out internal test set comprising 63 SSNs from 59 patients. 2D and 3D CT parameters, including consolidation-to-tumor ratio of volume (CTRV), were evaluated. Least absolute shrinkage and selection operator regression was used for feature selection, and models based on five machine-learning algorithms were developed using 5×5-fold nested cross-validation within the training set. The best-performing 2D and 3D models were selected according to the area under the receiver operating characteristic curve (AUC) calculated from pooled out-of-fold (OOF) predictions and were subsequently evaluated in the held-out test set. Model performance was assessed in terms of discrimination, calibration, and decision curve analysis, and AUCs were compared using the paired DeLong test. Results: The best-performing 2D and 3D models were 2D-XGB and 3D-RF, respectively, with pooled OOF AUCs of 0.713 (0.632-0.790) and 0.712 (0.633-0.785). In the held-out test set, 2D-XGB achieved an AUC of 0.766 (0.648-0.869), whereas 3D-RF achieved an AUC of 0.847 (0.745-0.931). No significant difference in AUC was observed between the two models based on either the pooled OOF predictions or the held-out test set predictions. Permutation importance analysis indicated that consolidation-to-tumor ratio was the most influential feature in 2D-XGB, whereas mass and CTRV Conclusions: Both 2D- and 3D-based models showed comparable discriminative performance for predicting the degree of invasion in lung non-mucinous adenocarcinomas presenting as SSNs. The 3D-RF model showed better calibration and a broader range of clinical net benefit, suggesting potential advantages for risk estimation and clinical decision-making. Mass and CTRV derived from multiple density thresholds may provide additional information for characterizing solid components and may support clinical decision-making.

Indexed as

consolidation-to-tumor ratio of volumelung adenocarcinomamachine learningsubsolid nodulesthree-dimensional

Identifiers

PMID42818581
PMCPMC13623560

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.